Cargando…

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Zhao, Xiwu, Li, Jian, Yu, Dapeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448298/ https://www.ncbi.nlm.nih.gov/pubmed/36004489 http://dx.doi.org/10.3892/ijmm.2022.5181

Ejemplares similares

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway
por: Zhao, Xiwu, et al.
Publicado: (2019)

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction]
Publicado: (2021)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021)

microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β-catenin pathway
por: Liu, Yilin, et al.
Publicado: (2022)

microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)

MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2022)

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway
por: Situ, Jie, et al.
Publicado: (2020)

MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway
por: Lv, Zhongzhe, et al.
Publicado: (2019)

MicroRNA-432 inhibits the aggressiveness of glioblastoma multiforme by directly targeting IGF-1R
por: Chen, Xudong, et al.
Publicado: (2022)

microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway
por: Jia, Jianwu, et al.
Publicado: (2019)

MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway
por: Li, Cuihong, et al.
Publicado: (2019)

MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R
por: Zhang, Chunhong, et al.
Publicado: (2022)

microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway
por: Lv, Lili, et al.
Publicado: (2019)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2020)

MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction]
Publicado: (2021)

MicroRNA-448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway
por: Wu, Shen, et al.
Publicado: (2022)

[Retracted] MicroRNA‑1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling
por: Liu, Chao, et al.
Publicado: (2023)

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
por: Xiang, Yubo, et al.
Publicado: (2023)

MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway
por: Zhao, Yuying, et al.
Publicado: (2022)

MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling
por: Si, Fengzhi, et al.
Publicado: (2021)

Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction note: Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma
por: Taheriazam, Afshin, et al.
Publicado: (2016)

MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer
por: Xia, Huan, et al.
Publicado: (2021)

MicroRNA-766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
por: Zhao, Jianjie, et al.
Publicado: (2022)

MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction]
Publicado: (2023)

MicroRNA-21 increases cell viability and suppresses cellular apoptosis in non-small cell lung cancer by regulating the PI3K/Akt signaling pathway
por: Wang, Tao, et al.
Publicado: (2021)

Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway
por: Engineering, Journal of Healthcare
Publicado: (2023)

MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF-1R-mediated AKT and ERK pathways
por: Zhou, Fangzheng, et al.
Publicado: (2022)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction]
Publicado: (2021)

Retraction statement: MicroRNA‐21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway
Publicado: (2021)

MicroRNA-643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma
por: Wang, Huan, et al.
Publicado: (2022)

Retracted: miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2023)

MicroRNA-186 targets IGF-1R and exerts tumor-suppressing functions in glioma
por: Jiang, Jian, et al.
Publicado: (2022)

MicroRNA-625 inhibits the progression of non-small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway
por: Tan, Xiaoxia, et al.
Publicado: (2022)

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_leh7as389acg9drmp3ua6bq9po